{"entity":{"type":"insider","cik":"0001250379","url":"/insider/0001250379","json_url":"/insider/0001250379.json","name":"PERRY MICHAEL S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":15,"first":"2011-04-14","last":"2025-12-09","span_basis":"filed_date"},"name_variants":[{"name":"PERRY MICHAEL S","source":"filing","n_filings":15,"first_seen":"2011-04-14","last_seen":"2025-12-09"}],"transactions":[{"id":4139321,"accession":"0001250379-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001250379-25-000003","line_url":"/filing/0001250379-25-000003#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16250.0,"shares_display":"16,250","price_per_share":61.03,"price_display":"61.03","price_state":"stated","total_value":991737.5,"total_display":"991,737.50","shares_owned_after":115240.0,"shares_owned_after_display":"115,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-05","filed_date":"2025-12-09","scope":"insider"},{"id":6826645,"accession":"0001209191-22-058404","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-058404","line_url":"/filing/0001209191-22-058404#line-2","is_derivative":false,"issuer_cik":"0001250379","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001250379","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":7.18,"price_display":"7.18","price_state":"stated","total_value":1077000.0,"total_display":"1,077,000.00","shares_owned_after":229543.0,"shares_owned_after_display":"229,543","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-22","scope":"insider"},{"id":6097011,"accession":"0001209191-22-013222","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-013222","line_url":"/filing/0001209191-22-013222#line-3","is_derivative":false,"issuer_cik":"0001250379","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001250379","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10812.0,"shares_display":"10,812","price_per_share":8.74,"price_display":"8.74","price_state":"stated","total_value":94496.88,"total_display":"94,496.88","shares_owned_after":321712.0,"shares_owned_after_display":"321,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-24","filed_date":"2022-02-25","scope":"insider"},{"id":6692800,"accession":"0001209191-22-001318","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-001318","line_url":"/filing/0001209191-22-001318#line-3","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2628.0,"shares_display":"2,628","price_per_share":64.3,"price_display":"64.30","price_state":"stated","total_value":168980.4,"total_display":"168,980.40","shares_owned_after":87372.0,"shares_owned_after_display":"87,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-04","scope":"insider"},{"id":6692798,"accession":"0001209191-22-001318","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-001318","line_url":"/filing/0001209191-22-001318#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":65.12,"price_display":"65.12","price_state":"stated","total_value":104192.0,"total_display":"104,192.00","shares_owned_after":85772.0,"shares_owned_after_display":"85,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-04","scope":"insider"},{"id":6692797,"accession":"0001209191-22-001318","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-001318","line_url":"/filing/0001209191-22-001318#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":272.0,"shares_display":"272","price_per_share":66.25,"price_display":"66.25","price_state":"stated","total_value":18020.0,"total_display":"18,020.00","shares_owned_after":85500.0,"shares_owned_after_display":"85,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-04","scope":"insider"},{"id":5478223,"accession":"0001209191-21-054958","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-054958","line_url":"/filing/0001209191-21-054958#line-2","is_derivative":false,"issuer_cik":"0001250379","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001250379","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11220.0,"shares_display":"11,220","price_per_share":20.68,"price_display":"20.68","price_state":"stated","total_value":232029.6,"total_display":"232,029.60","shares_owned_after":237638.0,"shares_owned_after_display":"237,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-01","filed_date":"2021-09-07","scope":"insider"},{"id":5333853,"accession":"0001209191-21-038189","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-038189","line_url":"/filing/0001209191-21-038189#line-1","is_derivative":false,"issuer_cik":"0001250379","issuer_name":"AVITA Medical, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001250379","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23000.0,"shares_display":"23,000","price_per_share":17.33,"price_display":"17.33","price_state":"stated","total_value":398590.0,"total_display":"398,590.00","shares_owned_after":225104.0,"shares_owned_after_display":"225,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-04","scope":"insider"},{"id":5242729,"accession":"0001209191-21-001538","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-001538","line_url":"/filing/0001209191-21-001538#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director","officer_title":null,"security_title":"Common Stock Sold","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":76.09,"price_display":"76.09","price_state":"stated","total_value":304360.0,"total_display":"304,360.00","shares_owned_after":90000.0,"shares_owned_after_display":"90,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider"},{"id":2557858,"accession":"0001209191-20-050769","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-050769","line_url":"/filing/0001209191-20-050769#line-4","is_derivative":false,"issuer_cik":"0001250379","issuer_name":"Avita Therapeutics, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001250379","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":27.41,"price_display":"27.41","price_state":"stated","total_value":246690.0,"total_display":"246,690.00","shares_owned_after":425087.0,"shares_owned_after_display":"425,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-16","filed_date":"2020-09-16","scope":"insider"},{"id":2557852,"accession":"0001209191-20-050769","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-050769","line_url":"/filing/0001209191-20-050769#line-3","is_derivative":false,"issuer_cik":"0001250379","issuer_name":"Avita Therapeutics, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001250379","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23769.0,"shares_display":"23,769","price_per_share":27.23,"price_display":"27.23","price_state":"stated","total_value":647229.87,"total_display":"647,229.87","shares_owned_after":434087.0,"shares_owned_after_display":"434,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-15","filed_date":"2020-09-16","scope":"insider"},{"id":2557848,"accession":"0001209191-20-050769","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-050769","line_url":"/filing/0001209191-20-050769#line-2","is_derivative":false,"issuer_cik":"0001250379","issuer_name":"Avita Therapeutics, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001250379","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15092.0,"shares_display":"15,092","price_per_share":26.99,"price_display":"26.99","price_state":"stated","total_value":407333.08,"total_display":"407,333.08","shares_owned_after":457856.0,"shares_owned_after_display":"457,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-14","filed_date":"2020-09-16","scope":"insider"},{"id":3323750,"accession":"0001209191-20-050215","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-050215","line_url":"/filing/0001209191-20-050215#line-3","is_derivative":false,"issuer_cik":"0001250379","issuer_name":"Avita Therapeutics, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001250379","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":26.02,"price_display":"26.02","price_state":"stated","total_value":520400.0,"total_display":"520,400.00","shares_owned_after":404444.0,"shares_owned_after_display":"404,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-11","filed_date":"2020-09-11","scope":"insider"},{"id":3323746,"accession":"0001209191-20-050215","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-050215","line_url":"/filing/0001209191-20-050215#line-2","is_derivative":false,"issuer_cik":"0001250379","issuer_name":"Avita Therapeutics, Inc.","issuer_ticker":"RCEL","issuer_name_source":null,"issuer_url":"/issuer/0001250379","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7128.0,"shares_display":"7,128","price_per_share":26.26,"price_display":"26.26","price_state":"stated","total_value":187181.28,"total_display":"187,181.28","shares_owned_after":424444.0,"shares_owned_after_display":"424,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-10","filed_date":"2020-09-11","scope":"insider"},{"id":2140007,"accession":"0001209191-20-028978","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-028978","line_url":"/filing/0001209191-20-028978#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29900.0,"shares_display":"29,900","price_per_share":35.71,"price_display":"35.71","price_state":"stated","total_value":1067729.0,"total_display":"1,067,729.00","shares_owned_after":14100.0,"shares_owned_after_display":"14,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-12","filed_date":"2020-05-13","scope":"insider"},{"id":2140002,"accession":"0001209191-20-028978","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-028978","line_url":"/filing/0001209191-20-028978#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6100.0,"shares_display":"6,100","price_per_share":36.42,"price_display":"36.42","price_state":"stated","total_value":222162.0,"total_display":"222,162.00","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-12","filed_date":"2020-05-13","scope":"insider"},{"id":8647331,"accession":"0001209191-19-049237","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-049237","line_url":"/filing/0001209191-19-049237#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85000.0,"shares_display":"85,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":2550000.0,"total_display":"2,550,000.00","shares_owned_after":36000.0,"shares_owned_after_display":"36,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-11","filed_date":"2019-09-11","scope":"insider"},{"id":8647329,"accession":"0001209191-19-049237","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-049237","line_url":"/filing/0001209191-19-049237#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":28.9,"price_display":"28.90","price_state":"stated","total_value":2890000.0,"total_display":"2,890,000.00","shares_owned_after":121000.0,"shares_owned_after_display":"121,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-09","filed_date":"2019-09-11","scope":"insider"},{"id":5960827,"accession":"0001209191-18-021679","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-021679","line_url":"/filing/0001209191-18-021679#line-3","is_derivative":false,"issuer_cik":"0000921114","issuer_name":"AmpliPhi Biosciences Corp","issuer_ticker":"APHB","issuer_name_source":null,"issuer_url":"/issuer/0000921114","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":181820.0,"shares_display":"181,820","price_per_share":1.1,"price_display":"1.10","price_state":"stated","total_value":200002.0,"total_display":"200,002.00","shares_owned_after":411105.0,"shares_owned_after_display":"411,105","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-22","filed_date":"2018-03-26","scope":"insider"},{"id":5960823,"accession":"0001209191-18-021679","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-021679","line_url":"/filing/0001209191-18-021679#line-2","is_derivative":false,"issuer_cik":"0000921114","issuer_name":"AmpliPhi Biosciences Corp","issuer_ticker":"APHB","issuer_name_source":null,"issuer_url":"/issuer/0000921114","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":105015.0,"shares_display":"105,015","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":229285.0,"shares_owned_after_display":"229,285","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-09-19","filed_date":"2018-03-26","scope":"insider"},{"id":5960818,"accession":"0001209191-18-021679","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-021679","line_url":"/filing/0001209191-18-021679#line-1","is_derivative":false,"issuer_cik":"0000921114","issuer_name":"AmpliPhi Biosciences Corp","issuer_ticker":"APHB","issuer_name_source":null,"issuer_url":"/issuer/0000921114","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5757.0,"shares_display":"5,757","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":124270.0,"shares_owned_after_display":"124,270","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-29","filed_date":"2018-03-26","scope":"insider"},{"id":3330250,"accession":"0001179110-12-005877","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-005877","line_url":"/filing/0001179110-12-005877#line-1","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Officer (President & CMO)","officer_title":"President & CMO","security_title":"Common Stock (PARD)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1599.0,"shares_display":"1,599","price_per_share":0.8317,"price_display":"0.83","price_state":"stated","total_value":1329.8883,"total_display":"1,329.89","shares_owned_after":8920.0,"shares_owned_after_display":"8,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-27","filed_date":"2012-03-27","scope":"insider"},{"id":3371104,"accession":"0001179110-12-003010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-003010","line_url":"/filing/0001179110-12-003010#line-1","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Officer (President & CMO)","officer_title":"President & CMO","security_title":"Common Stock (PARD)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6346.0,"shares_display":"6,346","price_per_share":0.8679,"price_display":"0.87","price_state":"stated","total_value":5507.6934,"total_display":"5,507.69","shares_owned_after":7719.0,"shares_owned_after_display":"7,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-16","filed_date":"2012-02-17","scope":"insider"},{"id":8922965,"accession":"0001179110-11-006477","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-11-006477","line_url":"/filing/0001179110-11-006477#line-1","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":"0001250379","owner_name":"PERRY MICHAEL S","owner_url":"/insider/0001250379","role":"Officer (President & CMO)","officer_title":"President & CMO","security_title":"Common Stock (PARD)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45140.0,"shares_display":"45,140","price_per_share":0.3736,"price_display":"0.37","price_state":"stated","total_value":16864.304,"total_display":"16,864.30","shares_owned_after":81860.0,"shares_owned_after_display":"81,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-13","filed_date":"2011-04-14","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000879407","name":"ARROWHEAD PHARMACEUTICALS, INC.","url":"/issuer/0000879407","role":"Director","n_filings":5,"first_seen":"2019-09-11","last_seen":"2025-12-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001762303","name":"AVITA Medical, Inc.","url":"/issuer/0001762303","role":"Director, Officer (Chief Executive Officer)","n_filings":6,"first_seen":"2020-09-11","last_seen":"2022-11-22"},{"type":"issuer","type_label":"ISSUER","cik":"0000921114","name":"AmpliPhi Biosciences Corp","url":"/issuer/0000921114","role":"Director","n_filings":1,"first_seen":"2018-03-26","last_seen":"2018-03-26"},{"type":"issuer","type_label":"ISSUER","cik":"0000755806","name":"PONIARD PHARMACEUTICALS, INC.","url":"/issuer/0000755806","role":"Officer (President & CMO)","n_filings":3,"first_seen":"2011-04-14","last_seen":"2012-03-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001250379","retrieved_at":"2026-08-20T22:17:51+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}